Skip to content

Fear conditioning and cortisol

Fear conditioning and cortisol - CCT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00010684
Enrollment
60
Registered
2016-07-04
Start date
2016-05-30
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy participants

Interventions

Group 1: single oral dose of Hydrocortison (30mg) immediatly after extinktion in a fear conditioning paradigm with aversiv film clips Group 2: single dose of placebo

Sponsors

Universität des Saarlandes, Klinische Psychologie und Psychotherapie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: healthy and normal weight participants, age between 18 and 35 years, non-smokers for women: hormonel contraceptions

Exclusion criteria

Exclusion criteria: - acute or chronic somatic or psychiatric disorders - current or previous increase of intraocular pressure (glaucoma) - positive family history of cerebral seizures or arterial vascular anomalies (aneurysms) - vaccination in the last 2 months or (planned) in the following month - participation in pharmacological studies within the last month - an increased arterial blood pressure (greater than 140/90 mmHg) - pregnancy or lactation - taking medication (except occasionally aspirin or acetaminophen to no more than one week prior to study entry) - regular use of nicotine, alcohol or drugs - sexual and physical violence experiences - acute clinical depression - acute or chronic disease of the hearing apparatus (f.e.acute otitis media, tinnitus)

Design outcomes

Primary

MeasureTime frame
Continuous detection of physiological parameters (electrodermal activity, startle response and electrocardiogram) on each day of testing: during a 3 minute resting period, the conditioning trials (Day1: acquisition, Day 2: extinction, Day 3: Reinstatment) and then again in a 3 minute resting period, as a measure of physiological anxiety response. To assess the behavirol data we use subjective ratings before the stimulus onset, during stimulus presentation and and after the conditioning trials. The intrusives memories are collected using a diary during the three days of testing. The explicit memories of the movie contents are queried on the first day after the acquisition, and on the third day after the reinstatement with a specially developed recognition task. The load and disstress is recorded on the first and third day of testing with the Impact of Event Scale (IES-R) as well as particular subjective ratings (f.e. how anxious you feel). On all three days of testing saliva samples, assessing the endogenous cortisol levels, are conducted to estimate the reactivity of the subjects to the aversive films on teh first day and on cortisol administration on the second day.

Secondary

MeasureTime frame
predisposing factors: conditionability, stress reactivity, personality factors, basal cortisol levels and other peripheral physiological parameters (heart rate variability, blood pressure, respiration)

Countries

Germany

Contacts

Public ContactAlexandra-Heike Gräbener

Universität des Saarlandes, Klinische Psychologie und Psychotherapie

alexandraheike.graebener@uni-saarland.de0681 302 71036

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026